Circulation: Cardiovascular Interventions Circulation: Cardiovascular Interventions RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Letter by Calabro and Gragnano Regarding Article, "Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials" [Letter to the Editor]
(Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 11, 2017 Category: Cardiology Authors: Calabro, P., Gragnano, F. Tags: Percutaneous Coronary Intervention, Revascularization, Stent Letter to the Editor Source Type: research

Time-Course Reduction in Patient Exposure to Radiation From Coronary Interventional Procedures: The Greater Paris Area Percutaneous Coronary Intervention Registry [Coronary Interventions]
Conclusions— In a large patient population, a steady temporal decrease in patient radiation exposure during CA and PCI was noted between 2009 and 2013. Kerma area product reduction was consistent in all types of procedure and was independent of patient-related factors and PCI procedure complexity. (Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 11, 2017 Category: Cardiology Authors: Georges, J.-L., Karam, N., Tafflet, M., Livarek, B., Bataille, S., Loyeau, A., Mapouata, M., Benamer, H., Caussin, C., Garot, P., Varenne, O., Barbou, F., Teiger, E., Funck, F., Karrillon, G., Lambert, Y., Spaulding, C., Jouven, X., for the CARDIO-ARSIF R Tags: Epidemiology, Angiography, Percutaneous Coronary Intervention, Quality and Outcomes Coronary Interventions Source Type: research

Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIX [Pharmacology]
Conclusions— Patients ≥75 years old have an overall 3-fold increased odds of moderate/severe bleeding. Cangrelor, when compared with clopidogrel, provides similar efficacy and in patients ≥75 years old as in those <75 years old but does not increase the risk of major bleeding. Clinical Trial Registration— URL: https://www.clinicaltrials.gov. Unique identifier: NCT01156571. (Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 11, 2017 Category: Cardiology Authors: Cavender, M. A., Bhatt, D. L., Stone, G. W., Steg, P. G., Gibson, C. M., Hamm, C. W., Price, M. J., Prats, J., Elkin, S., Deliargyris, E. N., Mahaffey, K. W., White, H. D., Harrington, R. A., on behalf of the CHAMPION PHOENIX Investigators* Tags: Anticoagulants, Percutaneous Coronary Intervention, Pharmacology Source Type: research

Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds: Magmaris Versus Absorb in a Porcine Arteriovenous Shunt Model [Coronary Interventions]
Conclusions— Despite a similar scaffold strut thickness, the Magmaris sirolimus-eluting bioabsorbable magnesium scaffold was significantly less thrombogenic compared with the Absorb bioresorbable vascular scaffold in an ex vivo porcine arteriovenous shunt model. Further studies are needed to determine whether the reduced thrombogenicity of Magmaris will result in reductions in major cardiovascular events. (Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 11, 2017 Category: Cardiology Authors: Waksman, R., Lipinski, M. J., Acampado, E., Cheng, Q., Adams, L., Torii, S., Gai, J., Torguson, R., Hellinga, D. M., Westman, P. C., Joner, M., Zumstein, P., Kolodgie, F. D., Virmani, R. Tags: Stent Coronary Interventions Source Type: research

Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study [Congenital Heart Disease]
Conclusions— Closure of atrial septal defect with the AMPLATZER Septal Occluder is safe and effective. The rate of hemodynamic compromise and cardiac erosion is rare. The risk factors for cardiac erosion after device closure are not yet clear. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00650936. (Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 11, 2017 Category: Cardiology Authors: Turner, D. R., Owada, C. Y., Sang, C. J., Khan, M., Lim, D. S. Tags: Congenital Heart Disease Source Type: research

Low-Flow Severe Aortic Stenosis: Evolving Role of Transcatheter Aortic Valve Replacement [Advances in Interventional Cardiology]
The definition of severe aortic stenosis has classically and retrospectively been based on the natural history of patients with medically managed aortic stenosis and preserved left ventricular function in an era where surgical aortic valve replacement was the sole therapy. We now recognize that this disease is more heterogeneous and includes important subsets of patients with low stroke volume index (low flow) and low-gradient with reduced (classical) or preserved (paradoxical) ejection fraction. These patients pose diagnostic and treatment dilemmas, requiring a comprehensive assessment with integration of multimodality im...
Source: Circulation: Cardiovascular Interventions - August 9, 2017 Category: Cardiology Authors: Saybolt, M. D., Fiorilli, P. N., Gertz, Z. M., Herrmann, H. C. Tags: Valvular Heart Disease, Catheter-Based Coronary and Valvular Interventions Advances in Interventional Cardiology Source Type: research

Noninferiority Trials in Interventional Cardiology [Editor's Perspective]
(Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 8, 2017 Category: Cardiology Authors: Kolte, D., Aronow, H. D., Abbott, J. D. Tags: Clinical Studies, Catheter-Based Coronary and Valvular Interventions Editor ' s Perspective Source Type: research

Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation [Coronary Interventions]
Conclusions— A higher post-PCI FFR value is associated with a better vessel-related outcome. However, its predictive value is too low to advocate its use as a surrogate clinical end point. (Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 8, 2017 Category: Cardiology Authors: Piroth, Z., Toth, G. G., Tonino, P. A. L., Barbato, E., Aghlmandi, S., Curzen, N., Rioufol, G., Pijls, N. H. J., Fearon, W. F., Juni, P., De Bruyne, B. Tags: Catheter-Based Coronary and Valvular Interventions, Percutaneous Coronary Intervention, Stent Coronary Interventions Source Type: research

Response by Mahmoud et al to Letter Regarding Article, "Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents: A Meta-Analysis of Randomized Trials" [Letter to the Editor]
(Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 2, 2017 Category: Cardiology Authors: Mahmoud, A. N., Barakat, A. F., Elgendy, A. Y., Schneibel, E., Mentias, A., Abuzaid, A., Elgendy, I. Y. Tags: Catheter-Based Coronary and Valvular Interventions Letter to the Editor Source Type: research

Combining Transcatheter Aortic Valve Replacement and Coronary Angiography/Percutaneous Coronary Intervention Procedures: Ready for Prime Time? [Editorials]
(Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 2, 2017 Category: Cardiology Authors: Rodes-Cabau, J. Tags: Aortic Valve Replacement/Transcatheter Aortic Valve Implantation, Catheter-Based Coronary and Valvular Interventions, Percutaneous Coronary Intervention Editorials Source Type: research

Platelet Transfusion for Ticagrelor Reversal [Editorials]
(Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 2, 2017 Category: Cardiology Authors: Kruger, P., Chan, N., Eikelboom, J. W. Tags: Coronary Artery Disease Editorials Source Type: research

Letter by Kounis et al Regarding Article, "Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents: A Meta-Analysis of Randomized Trials" [Letter to the Editor]
(Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 2, 2017 Category: Cardiology Authors: Kounis, N. G., Koniari, I., Hahalis, G. Tags: Inflammatory Heart Disease, Myocardial Infarction Letter to the Editor Source Type: research

Low Endothelial Shear Stress Predicts Evolution to High-Risk Coronary Plaque Phenotype in the Future: A Serial Optical Coherence Tomography and Computational Fluid Dynamics Study [Coronary Artery Disease]
Conclusions— Low ESS is significantly associated with baseline high-risk plaque phenotype and progression to higher-risk phenotype at 6 months. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT01110538. (Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 2, 2017 Category: Cardiology Authors: Yamamoto, E., Siasos, G., Zaromytidou, M., Coskun, A. U., Xing, L., Bryniarski, K., Zanchin, T., Sugiyama, T., Lee, H., Stone, P. H., Jang, I.-K. Tags: Atherosclerosis Coronary Artery Disease Source Type: research

Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement [Structural Heart Disease]
Conclusions— In patients undergoing TAVR, screening of CAD with invasive coronary angiography and ad hoc PCI during TAVR is feasible and was not associated with increased periprocedural risks. PCI followed by TAVR in the same session had similar outcomes than TAVR in which PCI was not performed. (Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 2, 2017 Category: Cardiology Authors: Barbanti, M., Todaro, D., Costa, G., Pilato, G., Picci, A., Gulino, S., Capranzano, P., La Spina, K., Di Simone, E., DArrigo, P., Deste, W., Indelicato, A., Cannata, S., Giannazzo, D., Imme, S., Tamburino, C., Patane, M., Buccheri, S., Capodanno, D., Sgro Tags: Diagnostic Testing, Aortic Valve Replacement/Transcatheter Aortic Valve Implantation Structural Heart Disease Source Type: research

Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With Ticagrelor [Coronary Artery Disease]
Conclusions— Platelet reactivity of ticagrelor-treated patients can be restored using concentrated platelets after a loading dose/maintenance therapy in a time-dependent manner under in vitro testing. Although statistically significant improvements are evident 6 hours after (last) dosing, ≤24 hours maybe needed for clinically meaningful restoration in platelet function. Clinical Trial Registration— URL: https://clinicaltrials.gov. Unique identifier: NCT02201394. (Source: Circulation: Cardiovascular Interventions)
Source: Circulation: Cardiovascular Interventions - August 2, 2017 Category: Cardiology Authors: Zafar, M. U., Smith, D. A., Baber, U., Sartori, S., Chen, K., Lam, D. W., Linares-Koloffon, C. A., Rey-Mendoza, J., Jimenez Britez, G., Escolar, G., Fuster, V., Badimon, J. J. Tags: Clinical Studies, Translational Studies, Cardiovascular Surgery Coronary Artery Disease Source Type: research